Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines
Cann American Corp.
320 Santana Dr. #C
Cloverdale, CA 95425
_______________________________
770-866-6250
cannamericancorp.com
cannamericanholdings@gmail.com
6719
Quarterly Report
For the Period Ending: 11/30/2021
(the "Reporting Period")
As of 11/30/2021, the number of shares outstanding of our Common Stock was:
265,000,186
As of 08/31/2021, the number of shares outstanding of our Common Stock was:
205,000,186
As of 02/28/2021, the number of shares outstanding of our Common Stock was:
205,000,186
Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934):
Yes: ☐ | No: ☒ |
Indicate by check mark whether the company's shell status has changed since the previous reporting period:
Yes: ☐ | No: ☒ |
Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period:
Yes: ☐ | No: ☒ |
- Name and address(es) of the issuer and its predecessors (if any)
In answering this item, provide the current name of the issuer any names used by predecessor entities, along with the dates of the name changes.
Cann American Corp as of 12/20/2019 - 320 Santana Dr., #C, Cloverdale, CA 95425
Canamed4Pets, Inc. as of 11/25/2014
Bioflamex Corp. as of 01/25/2011
Deerbay Resources Inc. as of 08/25/2004
OTC Markets Group Inc. | Page 1 of 9 |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) |
The state of incorporation or registration of the issuer and of each of its predecessors (if any) during the past five years; Please also include the issuer's current standing in its state of incorporation (e.g. active, default, inactive):
The company was incorporate on 08/25/2004 under the laws of the state of Nevada as Deer Bay Resources Inc. The company was re-named Bioflamex Corp. on 01/25/2011
The company was re-domiciled to the state of Wyoming on 02/20/2013 The company was re-named Canamed4Pets, Inc. on 11/25/2014 The company was re-named Cann American Corp on 12/20/2019 The Issuer's current standing is active with the state of Wyoming
Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:
None
List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:
The company completed a 1:10 reverse stock split of common shares on 11/13/2020
The address(es) of the issuer's principal executive office:
320 Santana Dr., #C, Cloverdale, CA 95425
The address(es) of the issuer's principal place of business:
Check box if principal executive office and principal place of business are the same address: ☒
Has the issuer or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five years?
Yes: ☐ | No: ☒ |
If this issuer or any of its predecessors have been the subject of such proceedings, please provide additional details in the space below:
None
2) | Security Information | ||
Trading symbol: | CNNA | ||
Exact title and class of securities outstanding: | Common | ||
CUSIP: | 13764N207 | ||
Par or stated value: | .0001 | ||
Total shares authorized: | 1,998,000,000 | as of date: 09/16/2020 | |
Total shares outstanding: | 265,000,186as of date: 11/30/2021 | ||
Number of shares in the Public Float2: | 167,422,834as of date: 11/30/2021 | ||
Total number of shareholders of record: | 18 | as of date: 11/30/2021 |
All additional class(es) of publicly traded securities (if any):
2 "Public Float" shall mean the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding (a "control person"), or any affiliates thereof, or any immediate family members of officers, directors and control persons.
OTC Markets Group Inc. | Page 2 of 9 |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) |
Trading symbol: | CNNA | |||
Exact title and class of securities outstanding: | Series A Preferred | |||
Par or stated value: | .00001 | |||
Total shares authorized: | 500,000 | as of date: 09/16/2020 | ||
Total shares outstanding: | 500,000 | as of date: 11/30/2021 | ||
Trading symbol: | CNNA | |||
Exact title and class of securities outstanding: | Series B Preferred | |||
Par or stated value: | .00001 | as of date: 09/16/2020 | ||
Total shares authorized: | 1,500,000 | |||
Total shares outstanding: | 1,500,000 | as of date: 11/30/2021 | ||
Transfer Agent | ||||
Name: | Securities Transfer Corp. | |||
Phone: | 469-633-0101 | |||
Email: | info@stctransfer.com | |||
Is the Transfer Agent registered under the Exchange Act?7 | Yes: ☒ | No: ☐ |
- Issuance History
A. Changes to the Number of Outstanding Shares
Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods: ☐
Shares Outstanding as of Second Most Recent Fiscal | |||||||||||
Year End: | *Right-click the rows below and select "Insert" to add rows as needed. | ||||||||||
Opening Balance : | |||||||||||
Date: 03/01/2019 | |||||||||||
Common: 8,981,888,621 | |||||||||||
Preferred: 1,000,000 | |||||||||||
Date of | Transaction type | Number of Shares | Class of | Value of | Were the | Individual/ | Reason for | Restricted or | Exemption | ||
Transaction | (e.g. new | Issued (or | Securities | shares | shares | Entity Shares | share | Unrestricted | or | ||
issuance, | cancelled) | issued | issued at a | were issued to | issuance | as of this | Registration | ||||
cancellation, | ($/per | discount to | (entities must | (e.g. for cash | filing. | Type. | |||||
shares returned | share) at | market | have individual | or debt | |||||||
to treasury) | Issuance | price at the | with voting / | conversion) | |||||||
time of | investment | -OR- | |||||||||
issuance? | control | Nature of | |||||||||
(Yes/No) | disclosed). | Services | |||||||||
Provided | |||||||||||
05/06/2019 | Cancellation | 3,173,897,240 | Common | .0001 | Yes | Henrik | Salary | Restricted | None | ||
Dahlerup | |||||||||||
06/21/2019 | Cancellation | 4,160,000,000 | Common | .0001 | Yes | Kristian | Salary | Restricted | None | ||
Schiorring | |||||||||||
06/21/2019 | Cancellation | 250,000 | Series A | .00001 | No | Henrik | Salary | Restricted | None | ||
Dahlerup | |||||||||||
7 To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act.
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 3 of 9 |
06/21/2019 | Cancellation | 250,000 | Series A | .00001 | No | Kristian | Salary | Restricted | None |
Schiorring | |||||||||
06/21/2019 | Cancellation | 250,000 | Series B | .00001 | No | Henrik | Salary | Restricted | None |
Dahlerup | |||||||||
06/21/2019 | Cancellation | 250,000 | Series B | .00001 | No | Kristian | Salary | Restricted | None |
Schiorring | |||||||||
08/01/2019 | New | 10,000,000 | Common | .005 | No | Patrick | Asset | Restricted | None |
Issuance | Post R/S | King | Purchase | ||||||
1,000,000 | |||||||||
08/21/2019 | New | 500,000 | Series A | .00001 | No | Jason | Asset | Restricted | None |
Issuance | Black | Purchase | |||||||
08/21/2019 | New | 1,500,000 | Series B | .00001 | No | Jason | Asset | Restricted | None |
Issuance | Black | Purchase | |||||||
09/09/2019 | New | 2,000,000 | Common | .001 | No | Patrick | Cash | Restricted | None |
Issuance | Post R/S | Young | |||||||
200,000 | |||||||||
02/10/2020 | New | 33,333,334 | Common | .0015 | Yes | GPL | Cash | Unrestricted | Reg-A |
Issuance | Post R/S | Ventures | |||||||
3,333,334 | Alexander | ||||||||
Dillon | |||||||||
05/27/2020 | New | 96,666,667 | Common | .0015 | Yes | Capitol | Business | Unrestricted | Reg-A |
Issuance | Post R/S | Capital Corp. | Consulting | ||||||
9,666,667 | Howard | Services | |||||||
Salamon | |||||||||
06/08/2020 | New | 110,000,000 | Common | .0015 | Yes | World Market | Services | Unrestricted | Reg-A |
Issuance | Post R/S | Ventures | Web | ||||||
11,000,000 | Chad Curtis | Design | |||||||
06/11/2020 | New | 6,666,667 | Common | .0015 | Yes | World Market | Cash | Unrestricted | Reg-A |
Issuance | Post R/S | Ventures | |||||||
666,667 | Chad Curtis | ||||||||
06/23/2020 | New | 33,333,334 | Common | .0015 | Yes | GPL | Cash | Unrestricted | Reg-A |
Issuance | Post R/S | Ventures | |||||||
3,333,334 | Alexander | ||||||||
Dillon | |||||||||
OTC Markets Group Inc. | Page 4 of 9 |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) |
07/07/2020 | New | 100,000,000 | Common | .0015 | Yes | Capitol Capital | Cash | Unrestricted | RegA | ||||
Issuance | Post R/S | Corp | |||||||||||
10,000,000 | Howard | ||||||||||||
Salamon | |||||||||||||
07/30/2020 | New | 10,000,000 | Common | .001 | Yes | John Cerenzia | Services | Restricted | RegA | ||||
Issuance | Post R/S | Consulting | |||||||||||
1,000,000 | |||||||||||||
09/16/2021 | New | 20,000,000 | Common | .0001 | Yes | Capitol Capital | Cash | Unrestricted | 144 | ||||
Issuance | Corp | ||||||||||||
Howard | |||||||||||||
Salamon | |||||||||||||
09/24/2021 | New | 20,000,000 | Common | .0001 | Yes | Capitol Capital | Cash | Unrestricted | 144 | ||||
Issuance | Corp | ||||||||||||
Howard | |||||||||||||
Salamon | |||||||||||||
10/05/2021 | New | 20,000,000 | Common | .0001 | Yes | Capitol Capital | Services | Unrestricted | 144 | ||||
Issuance | Corp | Consulting | |||||||||||
Howard | |||||||||||||
Salamon | |||||||||||||
Shares Outstanding on Date of This Report: | |||||||||||||
Ending Balance: | |||||||||||||
Date: 11/30/2021 | |||||||||||||
Common: 265,000,186 | |||||||||||||
Preferred: 2,000,000 | |||||||||||||
B. Debt Securities, Including Promissory and Convertible Notes
Use the chart and additional space below to list and describe all outstanding promissory notes, convertible notes, convertible debentures, or any other debt instruments that may be converted into a class of the issuer's equity securities.
Check this box if there are no outstanding promissory, convertible notes or debt arrangements: ☐
Date of | Outstanding | Principal | Interest | Maturity | Conversion Terms (e.g. | Name of Noteholder | Reason |
Note | Balance ($) | Amount | Accrued | Date | pricing mechanism for | (entities must have | for |
Issuance | at | ($) | determining conversion of | individual with voting / | Issuance | ||
Issuance | instrument to shares) | investment control | (e.g. Loan, | ||||
($) | disclosed). | Services, | |||||
etc.) | |||||||
09/01/20 | $94,135 | $90,125 | $8111 | 09/02/21 | 9% per annum - .0001 | Capitol Capital Corp | Loan |
conversion | Howard Salamon | ||||||
12/01/20 | $75,000 | $70,830 | $4170 | 12/02/21 | 9% per annum - .001 | Capitol Capital Corp | Loan |
conversion | Howard Salamon | ||||||
06/01/21 | $29,962 | $28,675 | $643 | 06/02/22 | 9% per annum - .001 | Capitol Capital Corp | Loan |
conversion | Howard Salamon | ||||||
OTC Markets Group Inc. | Page 5 of 9 |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Cannamed4pets Inc. published this content on 10 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 January 2022 14:07:03 UTC.